Science Explorer Back to mapMap
Discussion
Topic · Oncology

Cancer Research and Treatment

Cancer Research and Treatment is a research topic within Oncology. Science Explorer counts 8.5k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the application of nanotechnology in the treatment and diagnosis of cancer. It includes studies on nanoparticles, biospectroscopic analysis of cancer cells, development of anti-cancer nano drugs, DNA/RNA interaction, photodynamic therapy, pharmacokinetics, and therapeutic nanomedicine using drug delivery systems. The research also explores the use of synchrotron radiation for various aspects of cancer treatment.

  • Nanoparticles
  • Cancer Cells
  • Biospectroscopic Study
  • Anti-Cancer Nano Drugs
  • Synchrotron Radiation
  • DNA/RNA Interaction
  • Photodynamic Therapy
  • Pharmacokinetics
  • Therapeutic Nanomedicine
  • Drug Delivery Systems
Research works
8.5k
fractional, since 1950
In the world top 10%
869
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+33%
the tick is no change
Largest producer
India
30% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cancer Research and Treatment research?

By volume, India and China publish the most (574 and 372 works in 2022-now).

By volume, 2022-now

  1. 1 India 574 works
  2. 2 China 372 works
  3. 3 United States 269 works
  4. 4 Indonesia 195 works
  5. 5 Iraq 124 works
  6. 6 Iran 111 works
  7. 7 Pakistan 98 works
  8. 8 Türkiye 70 works
  9. 9 Egypt 66 works
  10. 10 Nigeria 64 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

India: 29.5%China: 19.1%United States: 13.8%Indonesia: 10.0%6 others listed: 27.5%30%largest
India574 · 29.5%China372 · 19.1%United States269 · 13.8%Indonesia195 · 10.0%6 others listed534 · 27.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cancer Research and Treatment research?

By volume in 2022-now, University of Baghdad publishes the most Cancer Research and Treatment research, followed by Islamic Azad University, Tehran and All India Institute of Medical Sciences.

Who are the leading researchers in Cancer Research and Treatment?

The most-cited researchers publishing on Cancer Research and Treatment include Zulfiqar Ahmed Bhutta, Farshad Farzadfar and Yousef Saleh Khader.

  1. 1 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  2. 2 Farshad Farzadfar Iran 298k citations
  3. 3 Yousef Saleh Khader Jordan 274k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cancer Research and Treatment?

The most cited paper in Cancer Research and Treatment is "The Physical Activity Guidelines for Americans" (Katrina L. Piercy, Richard P. Troiano, Rachel Ballard et al., 2018), with 9,860 citations. Next come "Prevalence of Childhood and Adult Obesity in the United States, 2011-2012" (8,151) and "Health Effects of Overweight and Obesity in 195 Countries over 25 Years" (8,109).

Most cited papers
#PaperReleasedCitations
1 The Physical Activity Guidelines for Americans Katrina L. Piercy, Richard P. Troiano, Rachel Ballard et al. · JAMA Open access 12 Nov 2018 9,860
2 Prevalence of Childhood and Adult Obesity in the United States, 2011-2012 Cynthia L. Ogden, Margaret Deutsch Carroll, Brian K. Kit et al. · JAMA Open access 25 Feb 2014 8,151
3 Health Effects of Overweight and Obesity in 195 Countries over 25 Years The GBD 2015 Obesity Collaborators · New England Journal of Medicine Open access 12 Jun 2017 8,109
4 Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Bernard J. Escudier, Tim G Eisen, Walter Michael Stadler et al. · New England Journal of Medicine Open access 10 Jan 2007 4,813
5 Trypan Blue Exclusion Test of Cell Viability Warren Strober · Current Protocols in Immunology Open access Nov 2015 2,619
All 100 most cited papers, with filters and sorting

Where is Cancer Research and Treatment research done?

The largest centres of Cancer Research and Treatment research in 2022-now are Beijing (China), Baghdad (Iraq), Tehran (Iran) and Chennai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Baghdad.

Largest cities, 2022-now

  1. 1 BeijingChina 49 works
  2. 2 BaghdadIraq 49 works
  3. 3 TehranIran 44 works
  4. 4 ChennaiIndia 34 works
  5. 5 New DelhiIndia 33 works
  6. 6 GuangzhouChina 29 works
  7. 7 ShanghaiChina 28 works
  8. 8 LahorePakistan 25 works
  9. 9 DhakaBangladesh 21 works
  10. 10 CairoEgypt 21 works

Where it is the local speciality

  1. BaghdadIQ · 48.7 works9.0×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cancer Research and Treatment than the world average.

See Cancer Research and Treatment on the map

Where is the best place to study Cancer Research and Treatment?

Among universities, judged by research, Sichuan University, All India Institute of Medical Sciences and Sun Yat-sen University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 11.9%fractional works in this field (log) →share of work in the world top 10% →Sichuan UniversitySun Yat-sen UniversityAll India Institute …University of Baghdad
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sichuan UniversityChina 61.231.4%1.9×10 +84.9%
2All India Institute of Medical SciencesIndia 59.212.0%5.5×15 +170.6%
3Sun Yat-sen UniversityChina 57.719.3%2.1×11 +58.6%
4University of BaghdadIraq 54.21.7%10.6×18 +122.3%
5Cairo UniversityEgypt 49.916.9%4.5×8 +50.3%
6Islamic Azad University, TehranIran 49.212.6%3.7×15 -24.1%
7Hindu College of PharmacyIndia 48.96.6%52.0×13 +133.6%
8Saveetha UniversityIndia 40.49.0%3.9×9 +351.5%
9Capital Medical UniversityChina 35.89.5%3.7×10 +369.0%
10University of KufaIraq 33.10.0%22.3×11 +133.7%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cancer Research and Treatment, country by country

Is Cancer Research and Treatment research growing?

Output in 2022-2025 was 33% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cancer Research and Treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cancer Research and Treatment as a percentage of every work published that year, 0.0089% in 2024.

still counting0.0050%0.010%0.015%Cancer Research and Treatment0.013% in 202519801990200020102020

Fractional works of Cancer Research and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cancer Research and Treatment10.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cancer Research and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.